Review





Similar Products

99
ATCC c2c12 mouse myoblasts
<t>C2C12</t> myoblast alignment, morphology, and proliferation on MXene multilayer coatings with different surface topographies. (a) Representative fluorescence images of F-actin (green) and nuclei (DAPI, blue) after 24 h of culture on Control, Planar, Nano, and Micro surfaces. Myoblasts on micro-wrinkled substrates exhibited pronounced elongation and alignment along the wrinkle axis. (b) SEM images showing cell–surface interactions and orientation; cells on micro-wrinkled coatings displayed elongated, anisotropic morphologies consistent with directional contact guidance. Quantitative analysis of (c) relative surface coverage and (d) relative average cell spreading area, both normalized to Control, and (e) aspect ratio. (f) Relative cell number over time indicating higher proliferation on Micro surfaces. Data are presented as mean ± SD ( n ≥ 3); statistical significance determined by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
C2c12 Mouse Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/C2C12/pmc13749387-153-0-3
Average 99 stars, based on 1 article reviews
c2c12 mouse myoblasts - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC c2c12 mouse myoblast cell line
<t>C2C12</t> myoblast alignment, morphology, and proliferation on MXene multilayer coatings with different surface topographies. (a) Representative fluorescence images of F-actin (green) and nuclei (DAPI, blue) after 24 h of culture on Control, Planar, Nano, and Micro surfaces. Myoblasts on micro-wrinkled substrates exhibited pronounced elongation and alignment along the wrinkle axis. (b) SEM images showing cell–surface interactions and orientation; cells on micro-wrinkled coatings displayed elongated, anisotropic morphologies consistent with directional contact guidance. Quantitative analysis of (c) relative surface coverage and (d) relative average cell spreading area, both normalized to Control, and (e) aspect ratio. (f) Relative cell number over time indicating higher proliferation on Micro surfaces. Data are presented as mean ± SD ( n ≥ 3); statistical significance determined by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
C2c12 Mouse Myoblast Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/C2C12/pm42968638-275-1-9
Average 99 stars, based on 1 article reviews
c2c12 mouse myoblast cell line - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC c2c12 mouse myoblast cells
(A) Schematic depicting the structural domains of VGLL2::NCOA2 and regions removed in domain deletion mutants. <t>C2C12</t> mouse myoblast cells transfected with pcDNA3.1 empty vector control or pcDNA3.1 expressing 3’ end 3x FLAG-tag VGLL2::NCOA2 and mutants having either: 1) Tondu/Vg (TDU) domain removed, 2) activating domain 1 or 2 (AD1 or AD2) removed, or 3) dual deletions of TDU+AD1 and AD1+AD2 domains. The predicted molecular weight of each construct is indicated to the left. (B) Western blot of whole-cell protein lysates extracted from transfected C2C12 cells that were selected with Geneticin/G418 for two weeks and probed for FLAG and loading control β-actin. The predicted molecular weights for the full-length fusion and deletion mutants are: full-length (∼75-77 kDa), TDU (∼72-74 kDa), AD1 (∼61-63 kDa), AD2 (∼55-57 kDa), AD1+AD2 (∼42-44 kDa), TDU+AD1 (∼58-60 kDa). (C) Quantification of relative levels of FLAG in C2C12 transfected cells via densitometry analysis from western blotting in Panel (B). Data is normalized with respect to the full-length VGLL2::NCOA2 condition. Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. (D) Western blot of cytosolic and nuclear protein lysates extracted from transfected C2C12 cells that were selected for two weeks and probed for FLAG and loading control Tbp. (E) Quantification of nuclear:cytosolic ratio of FLAG in C2C12 transfected cells via densitometry analysis from the western blot in Panel (D). Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. *p<0.05, **p<0.01, ****p<0.0001, ns: not significant. (F) Quantification of relative nuclear and cytosolic FLAG levels in C2C12 transfected cells via densitometry analysis from the western blot in Panel (D). Data is normalized to the cytosolic full-length VGLL2::NCOA2 transfected condition. Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. **p<0.01, ***p<0.001, ****p<0.0001, ns: not significant. (G) Western blot of three technical replicates of cytosolic and nuclear protein lysates extracted from C2C12 cells transfected with full-length VGLL2::NCOA2 and dual deleted TDU+AD1 domains and probed for FLAG and loading control Tbp. (H) Quantification of nuclear:cytosolic ratio of FLAG in C2C12 transfected cells via densitometry analysis from the western blot in Panel (G). Data indicate mean ± SD for n=3 technical replicates. The p values were calculated using a T-test with Welch’s correction. ***p<0.001.
C2c12 Mouse Myoblast Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/C2C12/bio_rxiv__64898__2026__11__01__763468-58-0-7
Average 99 stars, based on 1 article reviews
c2c12 mouse myoblast cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC c2c12 immortalized mouse skeletal myoblasts
(A) Schematic of the <t>C2C12</t> differentiation time course from proliferating myoblasts (Day −1) to differentiating cells (Days 1 and 2), with the corresponding Pax7 and MyoG expression patterns. (B) Genome browser tracks showing MyoG standard CUT&Tag and TF-CUT&Tag profiles over the Mymx locus at the indicated time points. (C) FRiP values for MyoG CUT&Tag and TF-CUT&Tag during differentiation, with matched IgG controls. (D) Volcano plot of DESeq2 results comparing Day 2 MyoG TF-CUT&Tag with H3K4me2 CUT&Tag. MyoG-enriched peaks (log2 fold change > 1 and adjusted P < 0.05) are shown in green, and the remaining peaks are shown in blue. monaLisa heatmap showing enrichment of myogenic E-box motifs across consecutive approximately 9,000-site bins ranked from H3K4me2-favored to MyoG TF-CUT&Tag-favored sites. (F) Scatterplot comparing normalized signal at merged MyoG peaks between Day 2 TF-CUT&Tag and standard CUT&Tag. Each point represents one peak; pink and navy denote TF-CUT&Tag-favored and standard-CUT&Tag-favored sites, respectively, among peaks with signal ≥1 in both conditions. (G) Differential AME motif enrichment in the site populations defined in (F), expressed as −log10(E-value). (H) Genome browser tracks showing Pax7 standard CUT&Tag and TF-CUT&Tag profiles across the Myf5/Myf6 locus during differentiation. (I) FRiP values for Pax7 and matched IgG controls at the indicated time points, as in (C). (J) Volcano plot comparing Pax7 TF-CUT&Tag at Day −1 with H3K4me2 CUT&Tag; Pax7-enriched peaks are shown in orange. (K) monaLisa heatmaps showing enrichment of Pax7- and Sp/KLF-associated motifs across peak bins ranked from H3K4me2-favored to Pax7 TF-CUT&Tag-favored sites at Day −1. (L) Stacked bar graphs showing the proportion of Pax7 peaks located in promoter/TSS-proximal or distal genomic regions for standard CUT&Tag and TF-CUT&Tag at Day −1 and Day 1. Promoter/TSS-proximal sites are shown in light blue and distal sites in purple. (M) Same as (J) but showing the Pax7 versus H3K4me2 CUT&Tag signal at Day 1. (N) Same as (K) but showing the enrichment of Pax7- and Sp/KLF-associated motifs across peak bins at Day 1.
C2c12 Immortalized Mouse Skeletal Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/C2C12/bio_rxiv__64898__2026__10__27__762201-386-0-5
Average 99 stars, based on 1 article reviews
c2c12 immortalized mouse skeletal myoblasts - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC mouse myoblast cell line c2c12
(A) Schematic of the <t>C2C12</t> differentiation time course from proliferating myoblasts (Day −1) to differentiating cells (Days 1 and 2), with the corresponding Pax7 and MyoG expression patterns. (B) Genome browser tracks showing MyoG standard CUT&Tag and TF-CUT&Tag profiles over the Mymx locus at the indicated time points. (C) FRiP values for MyoG CUT&Tag and TF-CUT&Tag during differentiation, with matched IgG controls. (D) Volcano plot of DESeq2 results comparing Day 2 MyoG TF-CUT&Tag with H3K4me2 CUT&Tag. MyoG-enriched peaks (log2 fold change > 1 and adjusted P < 0.05) are shown in green, and the remaining peaks are shown in blue. monaLisa heatmap showing enrichment of myogenic E-box motifs across consecutive approximately 9,000-site bins ranked from H3K4me2-favored to MyoG TF-CUT&Tag-favored sites. (F) Scatterplot comparing normalized signal at merged MyoG peaks between Day 2 TF-CUT&Tag and standard CUT&Tag. Each point represents one peak; pink and navy denote TF-CUT&Tag-favored and standard-CUT&Tag-favored sites, respectively, among peaks with signal ≥1 in both conditions. (G) Differential AME motif enrichment in the site populations defined in (F), expressed as −log10(E-value). (H) Genome browser tracks showing Pax7 standard CUT&Tag and TF-CUT&Tag profiles across the Myf5/Myf6 locus during differentiation. (I) FRiP values for Pax7 and matched IgG controls at the indicated time points, as in (C). (J) Volcano plot comparing Pax7 TF-CUT&Tag at Day −1 with H3K4me2 CUT&Tag; Pax7-enriched peaks are shown in orange. (K) monaLisa heatmaps showing enrichment of Pax7- and Sp/KLF-associated motifs across peak bins ranked from H3K4me2-favored to Pax7 TF-CUT&Tag-favored sites at Day −1. (L) Stacked bar graphs showing the proportion of Pax7 peaks located in promoter/TSS-proximal or distal genomic regions for standard CUT&Tag and TF-CUT&Tag at Day −1 and Day 1. Promoter/TSS-proximal sites are shown in light blue and distal sites in purple. (M) Same as (J) but showing the Pax7 versus H3K4me2 CUT&Tag signal at Day 1. (N) Same as (K) but showing the enrichment of Pax7- and Sp/KLF-associated motifs across peak bins at Day 1.
Mouse Myoblast Cell Line C2c12, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/C2C12/10__1038_slash_s41467___026___78375___2-363-1-6
Average 99 stars, based on 1 article reviews
mouse myoblast cell line c2c12 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC clonal selection 304 mouse myoblast c2c12 cells
(A) Schematic of the <t>C2C12</t> differentiation time course from proliferating myoblasts (Day −1) to differentiating cells (Days 1 and 2), with the corresponding Pax7 and MyoG expression patterns. (B) Genome browser tracks showing MyoG standard CUT&Tag and TF-CUT&Tag profiles over the Mymx locus at the indicated time points. (C) FRiP values for MyoG CUT&Tag and TF-CUT&Tag during differentiation, with matched IgG controls. (D) Volcano plot of DESeq2 results comparing Day 2 MyoG TF-CUT&Tag with H3K4me2 CUT&Tag. MyoG-enriched peaks (log2 fold change > 1 and adjusted P < 0.05) are shown in green, and the remaining peaks are shown in blue. monaLisa heatmap showing enrichment of myogenic E-box motifs across consecutive approximately 9,000-site bins ranked from H3K4me2-favored to MyoG TF-CUT&Tag-favored sites. (F) Scatterplot comparing normalized signal at merged MyoG peaks between Day 2 TF-CUT&Tag and standard CUT&Tag. Each point represents one peak; pink and navy denote TF-CUT&Tag-favored and standard-CUT&Tag-favored sites, respectively, among peaks with signal ≥1 in both conditions. (G) Differential AME motif enrichment in the site populations defined in (F), expressed as −log10(E-value). (H) Genome browser tracks showing Pax7 standard CUT&Tag and TF-CUT&Tag profiles across the Myf5/Myf6 locus during differentiation. (I) FRiP values for Pax7 and matched IgG controls at the indicated time points, as in (C). (J) Volcano plot comparing Pax7 TF-CUT&Tag at Day −1 with H3K4me2 CUT&Tag; Pax7-enriched peaks are shown in orange. (K) monaLisa heatmaps showing enrichment of Pax7- and Sp/KLF-associated motifs across peak bins ranked from H3K4me2-favored to Pax7 TF-CUT&Tag-favored sites at Day −1. (L) Stacked bar graphs showing the proportion of Pax7 peaks located in promoter/TSS-proximal or distal genomic regions for standard CUT&Tag and TF-CUT&Tag at Day −1 and Day 1. Promoter/TSS-proximal sites are shown in light blue and distal sites in purple. (M) Same as (J) but showing the Pax7 versus H3K4me2 CUT&Tag signal at Day 1. (N) Same as (K) but showing the enrichment of Pax7- and Sp/KLF-associated motifs across peak bins at Day 1.
Clonal Selection 304 Mouse Myoblast C2c12 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/C2C12/10__1016_slash_j__omta__2026__201857-112-6-13
Average 99 stars, based on 1 article reviews
clonal selection 304 mouse myoblast c2c12 cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC mouse c2c12 myoblasts
Shown are the results from the dual luciferase reporter assay in <t>C2C12</t> myotubes co-transfected with either the full-length h KCNH2 :LUC or Δh KCNH2 :LUC (E-box deletion) construct, together with BMAL1 and either wild-type CLOCK or the dominant-negative CLOCKΔ19. Relative luciferase activity (normalized to Renilla control) is shown for each condition. BMAL1:CLOCK transactivated the full-length h KCNH2 promoter. This transactivation was significantly reduced by co-expression of CLOCKΔ19 and by deletion of the tandem E-box. Co-expression of CLOCKΔ19 with the Δh KCNH2 :LUC construct did not further reduce promoter activity relative to Δh KCNH2 :LUC alone, indicating that BMAL1:CLOCK drives h KCNH2 transcription primarily through the tandem E-box. n = 14/3 separate transfections for h KCNH2 :LUC conditions; n = 8/3 separate transfections for Δh KCNH2 :LUC conditions. *p < 0.05, **p < 0.01.
Mouse C2c12 Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+myoblasts/C2C12/bio_rxiv__64898__2026__09__28__751769-41-0-3
Average 99 stars, based on 1 article reviews
mouse c2c12 myoblasts - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


C2C12 myoblast alignment, morphology, and proliferation on MXene multilayer coatings with different surface topographies. (a) Representative fluorescence images of F-actin (green) and nuclei (DAPI, blue) after 24 h of culture on Control, Planar, Nano, and Micro surfaces. Myoblasts on micro-wrinkled substrates exhibited pronounced elongation and alignment along the wrinkle axis. (b) SEM images showing cell–surface interactions and orientation; cells on micro-wrinkled coatings displayed elongated, anisotropic morphologies consistent with directional contact guidance. Quantitative analysis of (c) relative surface coverage and (d) relative average cell spreading area, both normalized to Control, and (e) aspect ratio. (f) Relative cell number over time indicating higher proliferation on Micro surfaces. Data are presented as mean ± SD ( n ≥ 3); statistical significance determined by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Journal: Biomaterials Science

Article Title: Tunable anisotropic nano/micro-topography aligns myotubes and accelerates maturation

doi: 10.1039/d6bm01020b

Figure Lengend Snippet: C2C12 myoblast alignment, morphology, and proliferation on MXene multilayer coatings with different surface topographies. (a) Representative fluorescence images of F-actin (green) and nuclei (DAPI, blue) after 24 h of culture on Control, Planar, Nano, and Micro surfaces. Myoblasts on micro-wrinkled substrates exhibited pronounced elongation and alignment along the wrinkle axis. (b) SEM images showing cell–surface interactions and orientation; cells on micro-wrinkled coatings displayed elongated, anisotropic morphologies consistent with directional contact guidance. Quantitative analysis of (c) relative surface coverage and (d) relative average cell spreading area, both normalized to Control, and (e) aspect ratio. (f) Relative cell number over time indicating higher proliferation on Micro surfaces. Data are presented as mean ± SD ( n ≥ 3); statistical significance determined by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Article Snippet: C2C12 mouse myoblasts (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Corning) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin (growth medium).

Techniques: Morphology, Fluorescence, Control, Analysis

Myogenic gene expression of C2C12 myoblasts cultured on MXene surfaces with different wrinkle dimensions. Relative mRNA expression levels of key myogenic markers—early (MyoD, Myogenin) and late (Acta1, Myh3, Mck) markers—were quantified after 2 days of proliferation followed by (a) 4 days and (b) 7 days of differentiation on Control, Planar, Nano, and Micro surfaces. Gene expression levels were normalized to GAPDH and expressed relative to the Control group. Data are presented as mean ± SD ( n = 3); statistical analysis performed by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant).

Journal: Biomaterials Science

Article Title: Tunable anisotropic nano/micro-topography aligns myotubes and accelerates maturation

doi: 10.1039/d6bm01020b

Figure Lengend Snippet: Myogenic gene expression of C2C12 myoblasts cultured on MXene surfaces with different wrinkle dimensions. Relative mRNA expression levels of key myogenic markers—early (MyoD, Myogenin) and late (Acta1, Myh3, Mck) markers—were quantified after 2 days of proliferation followed by (a) 4 days and (b) 7 days of differentiation on Control, Planar, Nano, and Micro surfaces. Gene expression levels were normalized to GAPDH and expressed relative to the Control group. Data are presented as mean ± SD ( n = 3); statistical analysis performed by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant).

Article Snippet: C2C12 mouse myoblasts (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Corning) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin (growth medium).

Techniques: Gene Expression, Cell Culture, Expressing, Control, Analysis

Effect of MXene surface topography on C2C12 myotube morphology and dimensional characteristics. (a) Representative fluorescence images showing F-actin (red), MHC (green), and nuclei (DAPI, blue) after 2 days of proliferation and 5 days of differentiation on Control, Planar, Nano, and Micro surfaces. (b) Quantitative analysis of myotube length, area, width, and fusion index (percentage of nuclei within MHC + myotubes containing ≥2 nuclei) (mean ± SD, n ≥ 3; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; two-way ANOVA).

Journal: Biomaterials Science

Article Title: Tunable anisotropic nano/micro-topography aligns myotubes and accelerates maturation

doi: 10.1039/d6bm01020b

Figure Lengend Snippet: Effect of MXene surface topography on C2C12 myotube morphology and dimensional characteristics. (a) Representative fluorescence images showing F-actin (red), MHC (green), and nuclei (DAPI, blue) after 2 days of proliferation and 5 days of differentiation on Control, Planar, Nano, and Micro surfaces. (b) Quantitative analysis of myotube length, area, width, and fusion index (percentage of nuclei within MHC + myotubes containing ≥2 nuclei) (mean ± SD, n ≥ 3; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; two-way ANOVA).

Article Snippet: C2C12 mouse myoblasts (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Corning) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin (growth medium).

Techniques: Surface Topography, Morphology, Fluorescence, Control, Analysis

Effect of MXene surface topography on sarcomeric α-actinin organization in C2C12 myotubes. (a) Representative fluorescence images showing sarcomeric α-actinin (green) and nuclei (DAPI, blue) after 2 days of proliferation and 5 days of differentiation on Control, Planar, Nano, and Micro surfaces. (b) Quantitative analysis of the length, width, and area of α-actinin-positive myotubes (mean ± SD, n ≥ 3; * p < 0.05, *** p < 0.001, **** p < 0.0001; two-way ANOVA).

Journal: Biomaterials Science

Article Title: Tunable anisotropic nano/micro-topography aligns myotubes and accelerates maturation

doi: 10.1039/d6bm01020b

Figure Lengend Snippet: Effect of MXene surface topography on sarcomeric α-actinin organization in C2C12 myotubes. (a) Representative fluorescence images showing sarcomeric α-actinin (green) and nuclei (DAPI, blue) after 2 days of proliferation and 5 days of differentiation on Control, Planar, Nano, and Micro surfaces. (b) Quantitative analysis of the length, width, and area of α-actinin-positive myotubes (mean ± SD, n ≥ 3; * p < 0.05, *** p < 0.001, **** p < 0.0001; two-way ANOVA).

Article Snippet: C2C12 mouse myoblasts (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Corning) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin (growth medium).

Techniques: Surface Topography, Fluorescence, Control, Analysis

(A) Schematic depicting the structural domains of VGLL2::NCOA2 and regions removed in domain deletion mutants. C2C12 mouse myoblast cells transfected with pcDNA3.1 empty vector control or pcDNA3.1 expressing 3’ end 3x FLAG-tag VGLL2::NCOA2 and mutants having either: 1) Tondu/Vg (TDU) domain removed, 2) activating domain 1 or 2 (AD1 or AD2) removed, or 3) dual deletions of TDU+AD1 and AD1+AD2 domains. The predicted molecular weight of each construct is indicated to the left. (B) Western blot of whole-cell protein lysates extracted from transfected C2C12 cells that were selected with Geneticin/G418 for two weeks and probed for FLAG and loading control β-actin. The predicted molecular weights for the full-length fusion and deletion mutants are: full-length (∼75-77 kDa), TDU (∼72-74 kDa), AD1 (∼61-63 kDa), AD2 (∼55-57 kDa), AD1+AD2 (∼42-44 kDa), TDU+AD1 (∼58-60 kDa). (C) Quantification of relative levels of FLAG in C2C12 transfected cells via densitometry analysis from western blotting in Panel (B). Data is normalized with respect to the full-length VGLL2::NCOA2 condition. Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. (D) Western blot of cytosolic and nuclear protein lysates extracted from transfected C2C12 cells that were selected for two weeks and probed for FLAG and loading control Tbp. (E) Quantification of nuclear:cytosolic ratio of FLAG in C2C12 transfected cells via densitometry analysis from the western blot in Panel (D). Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. *p<0.05, **p<0.01, ****p<0.0001, ns: not significant. (F) Quantification of relative nuclear and cytosolic FLAG levels in C2C12 transfected cells via densitometry analysis from the western blot in Panel (D). Data is normalized to the cytosolic full-length VGLL2::NCOA2 transfected condition. Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. **p<0.01, ***p<0.001, ****p<0.0001, ns: not significant. (G) Western blot of three technical replicates of cytosolic and nuclear protein lysates extracted from C2C12 cells transfected with full-length VGLL2::NCOA2 and dual deleted TDU+AD1 domains and probed for FLAG and loading control Tbp. (H) Quantification of nuclear:cytosolic ratio of FLAG in C2C12 transfected cells via densitometry analysis from the western blot in Panel (G). Data indicate mean ± SD for n=3 technical replicates. The p values were calculated using a T-test with Welch’s correction. ***p<0.001.

Journal: bioRxiv

Article Title: Structure-Function Analysis of an Infantile Rhabdomyosarcoma Fusion-Oncogene Reveals Domain Requirements for Tumorigenesis

doi: 10.64898/2026.11.01.763468

Figure Lengend Snippet: (A) Schematic depicting the structural domains of VGLL2::NCOA2 and regions removed in domain deletion mutants. C2C12 mouse myoblast cells transfected with pcDNA3.1 empty vector control or pcDNA3.1 expressing 3’ end 3x FLAG-tag VGLL2::NCOA2 and mutants having either: 1) Tondu/Vg (TDU) domain removed, 2) activating domain 1 or 2 (AD1 or AD2) removed, or 3) dual deletions of TDU+AD1 and AD1+AD2 domains. The predicted molecular weight of each construct is indicated to the left. (B) Western blot of whole-cell protein lysates extracted from transfected C2C12 cells that were selected with Geneticin/G418 for two weeks and probed for FLAG and loading control β-actin. The predicted molecular weights for the full-length fusion and deletion mutants are: full-length (∼75-77 kDa), TDU (∼72-74 kDa), AD1 (∼61-63 kDa), AD2 (∼55-57 kDa), AD1+AD2 (∼42-44 kDa), TDU+AD1 (∼58-60 kDa). (C) Quantification of relative levels of FLAG in C2C12 transfected cells via densitometry analysis from western blotting in Panel (B). Data is normalized with respect to the full-length VGLL2::NCOA2 condition. Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. (D) Western blot of cytosolic and nuclear protein lysates extracted from transfected C2C12 cells that were selected for two weeks and probed for FLAG and loading control Tbp. (E) Quantification of nuclear:cytosolic ratio of FLAG in C2C12 transfected cells via densitometry analysis from the western blot in Panel (D). Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. *p<0.05, **p<0.01, ****p<0.0001, ns: not significant. (F) Quantification of relative nuclear and cytosolic FLAG levels in C2C12 transfected cells via densitometry analysis from the western blot in Panel (D). Data is normalized to the cytosolic full-length VGLL2::NCOA2 transfected condition. Data indicate mean ± SD for n=3 trials. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. **p<0.01, ***p<0.001, ****p<0.0001, ns: not significant. (G) Western blot of three technical replicates of cytosolic and nuclear protein lysates extracted from C2C12 cells transfected with full-length VGLL2::NCOA2 and dual deleted TDU+AD1 domains and probed for FLAG and loading control Tbp. (H) Quantification of nuclear:cytosolic ratio of FLAG in C2C12 transfected cells via densitometry analysis from the western blot in Panel (G). Data indicate mean ± SD for n=3 technical replicates. The p values were calculated using a T-test with Welch’s correction. ***p<0.001.

Article Snippet: C2C12 mouse myoblast cells were obtained from American Type Culture Collection (ATCC Cat# CRL-1772, RRID:CVCL_0188) and were maintained in a humidified incubator at 37 ° C and 5% CO 2 .

Techniques: Transfection, Plasmid Preparation, Control, Expressing, FLAG-tag, Molecular Weight, Construct, Western Blot, Analysis

(A) Immunofluorescence staining of FLAG in C2C12 cells transfected with the full-length VGLL2::NCOA2 fusion-oncogene and domain deletion mutants. White arrows indicate cells with nuclear localized FLAG (VGLL2::NCOA2). Scale bars: 25 µm. (B) Correlation maps depicting co-localization of DAPI nuclear stain with FLAG (VGLL2::NCOA2) for different transfected C2C12 conditions. The Y-axis depicts DAPI pixel intensity and the X-axis depicts FLAG pixel intensity. Each white point represents the pixel intensity for DAPI and FLAG at the same location on the image. The number (white, top right) on the colocalization maps indicates the overlap coefficient between FLAG and DAPI. The greater the number of white dots in the purple region (shown in the schematic) corresponds to higher colocalization/higher overlap coefficient between DAPI and FLAG.. These results are representative of n=3 trials.

Journal: bioRxiv

Article Title: Structure-Function Analysis of an Infantile Rhabdomyosarcoma Fusion-Oncogene Reveals Domain Requirements for Tumorigenesis

doi: 10.64898/2026.11.01.763468

Figure Lengend Snippet: (A) Immunofluorescence staining of FLAG in C2C12 cells transfected with the full-length VGLL2::NCOA2 fusion-oncogene and domain deletion mutants. White arrows indicate cells with nuclear localized FLAG (VGLL2::NCOA2). Scale bars: 25 µm. (B) Correlation maps depicting co-localization of DAPI nuclear stain with FLAG (VGLL2::NCOA2) for different transfected C2C12 conditions. The Y-axis depicts DAPI pixel intensity and the X-axis depicts FLAG pixel intensity. Each white point represents the pixel intensity for DAPI and FLAG at the same location on the image. The number (white, top right) on the colocalization maps indicates the overlap coefficient between FLAG and DAPI. The greater the number of white dots in the purple region (shown in the schematic) corresponds to higher colocalization/higher overlap coefficient between DAPI and FLAG.. These results are representative of n=3 trials.

Article Snippet: C2C12 mouse myoblast cells were obtained from American Type Culture Collection (ATCC Cat# CRL-1772, RRID:CVCL_0188) and were maintained in a humidified incubator at 37 ° C and 5% CO 2 .

Techniques: Immunofluorescence, Staining, Transfection

C2C12 mouse myoblast cells were transfected with pcDNA3.1 empty vector or pcDNA3.1 expressing 3’ end 3x FLAG-tag VGLL2::NCOA2 and domain deletion mutants. After two weeks of selection, they were plated for colony formation experiments in soft agar. (A) Representative images of the soft agar colony formation assay at two weeks post plating, including an image of the entire well and a phase contrast image. Scale bars: 100 µm. (B,C,D) Quantification of the number of colonies per well in a six-well plate for different transfected conditions. Data bars indicate mean ± SD. This was repeated three times independently with six technical replicates. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. **p<0.01, ***p<0.001, ****p<0.0001, ns: not significant.

Journal: bioRxiv

Article Title: Structure-Function Analysis of an Infantile Rhabdomyosarcoma Fusion-Oncogene Reveals Domain Requirements for Tumorigenesis

doi: 10.64898/2026.11.01.763468

Figure Lengend Snippet: C2C12 mouse myoblast cells were transfected with pcDNA3.1 empty vector or pcDNA3.1 expressing 3’ end 3x FLAG-tag VGLL2::NCOA2 and domain deletion mutants. After two weeks of selection, they were plated for colony formation experiments in soft agar. (A) Representative images of the soft agar colony formation assay at two weeks post plating, including an image of the entire well and a phase contrast image. Scale bars: 100 µm. (B,C,D) Quantification of the number of colonies per well in a six-well plate for different transfected conditions. Data bars indicate mean ± SD. This was repeated three times independently with six technical replicates. The p values were calculated using a one-way ANOVA followed by Tukey’s multiple comparisons post hoc test. **p<0.01, ***p<0.001, ****p<0.0001, ns: not significant.

Article Snippet: C2C12 mouse myoblast cells were obtained from American Type Culture Collection (ATCC Cat# CRL-1772, RRID:CVCL_0188) and were maintained in a humidified incubator at 37 ° C and 5% CO 2 .

Techniques: Transfection, Plasmid Preparation, Expressing, FLAG-tag, Selection, Colony Assay, Soft Agar Assay, Phase Contrast

(A) Principal Component Analysis (after batch adjustment) of bulk RNA-seq expression data from C2C12 mouse myoblast controls or myoblasts expressing full-length VGLL2::NCOA2 or domain deletion mutants. (B) Hierarchical clustering of C2C12 transfection conditions based on normalized bulk RNA-seq expression data. (C, D) Hallmark gene sets enrichment plots detailing downregulated and upregulated gene sets in TDU domain deletion and AD1 domain deletion groups compared to the full-length VGLL2::NCOA2 condition. Reads were aligned to a custom mouse genome (mm39) that also included the human VGLL2::NCOA2 fusion-oncogene. Key downregulated gene sets are indicated by asterisks and upregulated gene sets by arrows.

Journal: bioRxiv

Article Title: Structure-Function Analysis of an Infantile Rhabdomyosarcoma Fusion-Oncogene Reveals Domain Requirements for Tumorigenesis

doi: 10.64898/2026.11.01.763468

Figure Lengend Snippet: (A) Principal Component Analysis (after batch adjustment) of bulk RNA-seq expression data from C2C12 mouse myoblast controls or myoblasts expressing full-length VGLL2::NCOA2 or domain deletion mutants. (B) Hierarchical clustering of C2C12 transfection conditions based on normalized bulk RNA-seq expression data. (C, D) Hallmark gene sets enrichment plots detailing downregulated and upregulated gene sets in TDU domain deletion and AD1 domain deletion groups compared to the full-length VGLL2::NCOA2 condition. Reads were aligned to a custom mouse genome (mm39) that also included the human VGLL2::NCOA2 fusion-oncogene. Key downregulated gene sets are indicated by asterisks and upregulated gene sets by arrows.

Article Snippet: C2C12 mouse myoblast cells were obtained from American Type Culture Collection (ATCC Cat# CRL-1772, RRID:CVCL_0188) and were maintained in a humidified incubator at 37 ° C and 5% CO 2 .

Techniques: Analysis, RNA Sequencing, Expressing, Transfection

(A) Tumor leg volume is plotted for each individual mouse as a function of days post injection (left). Cumulative mean tumor volume of all the tumor-bearing mice as a function of days post injection (right). Data indicate mean ± standard error of mean (SEM). p values were calculated by comparing the mean days of tumor onset using a Kruskal Wallis non-parametric ANOVA test corrected for multiple comparisons using the 2-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli. *p<0.05 with respect to comparing the full-length VGLL2::NCOA2 condition to all domain deletion mutant allograft tumors. (B) Survival plot indicating percentage of mice reaching tumor or humane endpoint for each condition as a function of days post injections. Cumulative statistical analysis was performed using Log-rank (Mantel-Cox) test and individual tests between two groups were performed using Log-rank (Mantel-Cox) test and confirmed using Gehan-Breslow-Wilcoxon test. ***p<0.001 with respect to comparing the full-length VGLL2::NCOA2 condition to all domain deletion mutant allograft tumors. (C) Stacked bar plot indicating the number of mice with tumors greater than 500 mm 3 volume, and number of mice with no tumors and tumors smaller than 500 mm 3 volume. (D) Representative hematoxylin-eosin (H&E) staining from a C2C12 VGLL2::NCOA2 full-length allograft and a C2C12 VGLL2::NCOA2 with domain deletions of TDU, AD1 and TDU+AD1 tumor allografts. Scale bars: 50 μm. (E) Pathological assessment of tumor cell morphology based on hematoxylin and eosin (HE)- stained slides in a semi-quantitative manner, using a three-tiered system: mostly (>75%) round/pleomorphic cells, mostly (>75%) spindle cells, or a combination of the above (mixed). Statistical significance was determined using a Chi-square test.

Journal: bioRxiv

Article Title: Structure-Function Analysis of an Infantile Rhabdomyosarcoma Fusion-Oncogene Reveals Domain Requirements for Tumorigenesis

doi: 10.64898/2026.11.01.763468

Figure Lengend Snippet: (A) Tumor leg volume is plotted for each individual mouse as a function of days post injection (left). Cumulative mean tumor volume of all the tumor-bearing mice as a function of days post injection (right). Data indicate mean ± standard error of mean (SEM). p values were calculated by comparing the mean days of tumor onset using a Kruskal Wallis non-parametric ANOVA test corrected for multiple comparisons using the 2-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli. *p<0.05 with respect to comparing the full-length VGLL2::NCOA2 condition to all domain deletion mutant allograft tumors. (B) Survival plot indicating percentage of mice reaching tumor or humane endpoint for each condition as a function of days post injections. Cumulative statistical analysis was performed using Log-rank (Mantel-Cox) test and individual tests between two groups were performed using Log-rank (Mantel-Cox) test and confirmed using Gehan-Breslow-Wilcoxon test. ***p<0.001 with respect to comparing the full-length VGLL2::NCOA2 condition to all domain deletion mutant allograft tumors. (C) Stacked bar plot indicating the number of mice with tumors greater than 500 mm 3 volume, and number of mice with no tumors and tumors smaller than 500 mm 3 volume. (D) Representative hematoxylin-eosin (H&E) staining from a C2C12 VGLL2::NCOA2 full-length allograft and a C2C12 VGLL2::NCOA2 with domain deletions of TDU, AD1 and TDU+AD1 tumor allografts. Scale bars: 50 μm. (E) Pathological assessment of tumor cell morphology based on hematoxylin and eosin (HE)- stained slides in a semi-quantitative manner, using a three-tiered system: mostly (>75%) round/pleomorphic cells, mostly (>75%) spindle cells, or a combination of the above (mixed). Statistical significance was determined using a Chi-square test.

Article Snippet: C2C12 mouse myoblast cells were obtained from American Type Culture Collection (ATCC Cat# CRL-1772, RRID:CVCL_0188) and were maintained in a humidified incubator at 37 ° C and 5% CO 2 .

Techniques: Injection, Mutagenesis, Analysis, H&E Stain, Staining, Morphology, Chi-Square

(A) Schematic of the C2C12 differentiation time course from proliferating myoblasts (Day −1) to differentiating cells (Days 1 and 2), with the corresponding Pax7 and MyoG expression patterns. (B) Genome browser tracks showing MyoG standard CUT&Tag and TF-CUT&Tag profiles over the Mymx locus at the indicated time points. (C) FRiP values for MyoG CUT&Tag and TF-CUT&Tag during differentiation, with matched IgG controls. (D) Volcano plot of DESeq2 results comparing Day 2 MyoG TF-CUT&Tag with H3K4me2 CUT&Tag. MyoG-enriched peaks (log2 fold change > 1 and adjusted P < 0.05) are shown in green, and the remaining peaks are shown in blue. monaLisa heatmap showing enrichment of myogenic E-box motifs across consecutive approximately 9,000-site bins ranked from H3K4me2-favored to MyoG TF-CUT&Tag-favored sites. (F) Scatterplot comparing normalized signal at merged MyoG peaks between Day 2 TF-CUT&Tag and standard CUT&Tag. Each point represents one peak; pink and navy denote TF-CUT&Tag-favored and standard-CUT&Tag-favored sites, respectively, among peaks with signal ≥1 in both conditions. (G) Differential AME motif enrichment in the site populations defined in (F), expressed as −log10(E-value). (H) Genome browser tracks showing Pax7 standard CUT&Tag and TF-CUT&Tag profiles across the Myf5/Myf6 locus during differentiation. (I) FRiP values for Pax7 and matched IgG controls at the indicated time points, as in (C). (J) Volcano plot comparing Pax7 TF-CUT&Tag at Day −1 with H3K4me2 CUT&Tag; Pax7-enriched peaks are shown in orange. (K) monaLisa heatmaps showing enrichment of Pax7- and Sp/KLF-associated motifs across peak bins ranked from H3K4me2-favored to Pax7 TF-CUT&Tag-favored sites at Day −1. (L) Stacked bar graphs showing the proportion of Pax7 peaks located in promoter/TSS-proximal or distal genomic regions for standard CUT&Tag and TF-CUT&Tag at Day −1 and Day 1. Promoter/TSS-proximal sites are shown in light blue and distal sites in purple. (M) Same as (J) but showing the Pax7 versus H3K4me2 CUT&Tag signal at Day 1. (N) Same as (K) but showing the enrichment of Pax7- and Sp/KLF-associated motifs across peak bins at Day 1.

Journal: bioRxiv

Article Title: Engineered Tn5 Variants Enhance CUT&Tag Fidelity for Transcription Factors

doi: 10.64898/2026.10.27.762201

Figure Lengend Snippet: (A) Schematic of the C2C12 differentiation time course from proliferating myoblasts (Day −1) to differentiating cells (Days 1 and 2), with the corresponding Pax7 and MyoG expression patterns. (B) Genome browser tracks showing MyoG standard CUT&Tag and TF-CUT&Tag profiles over the Mymx locus at the indicated time points. (C) FRiP values for MyoG CUT&Tag and TF-CUT&Tag during differentiation, with matched IgG controls. (D) Volcano plot of DESeq2 results comparing Day 2 MyoG TF-CUT&Tag with H3K4me2 CUT&Tag. MyoG-enriched peaks (log2 fold change > 1 and adjusted P < 0.05) are shown in green, and the remaining peaks are shown in blue. monaLisa heatmap showing enrichment of myogenic E-box motifs across consecutive approximately 9,000-site bins ranked from H3K4me2-favored to MyoG TF-CUT&Tag-favored sites. (F) Scatterplot comparing normalized signal at merged MyoG peaks between Day 2 TF-CUT&Tag and standard CUT&Tag. Each point represents one peak; pink and navy denote TF-CUT&Tag-favored and standard-CUT&Tag-favored sites, respectively, among peaks with signal ≥1 in both conditions. (G) Differential AME motif enrichment in the site populations defined in (F), expressed as −log10(E-value). (H) Genome browser tracks showing Pax7 standard CUT&Tag and TF-CUT&Tag profiles across the Myf5/Myf6 locus during differentiation. (I) FRiP values for Pax7 and matched IgG controls at the indicated time points, as in (C). (J) Volcano plot comparing Pax7 TF-CUT&Tag at Day −1 with H3K4me2 CUT&Tag; Pax7-enriched peaks are shown in orange. (K) monaLisa heatmaps showing enrichment of Pax7- and Sp/KLF-associated motifs across peak bins ranked from H3K4me2-favored to Pax7 TF-CUT&Tag-favored sites at Day −1. (L) Stacked bar graphs showing the proportion of Pax7 peaks located in promoter/TSS-proximal or distal genomic regions for standard CUT&Tag and TF-CUT&Tag at Day −1 and Day 1. Promoter/TSS-proximal sites are shown in light blue and distal sites in purple. (M) Same as (J) but showing the Pax7 versus H3K4me2 CUT&Tag signal at Day 1. (N) Same as (K) but showing the enrichment of Pax7- and Sp/KLF-associated motifs across peak bins at Day 1.

Article Snippet: C2C12 immortalized mouse skeletal myoblasts (ATCC CRL-1772) were maintained in DMEM with 4.5 g/L glucose, glutamine, and sodium pyruvate (Corning, 10–013-CV) with 10% FBS (Sigma, F0926) at 37°C in a humidified incubator containing 5% CO 2 .

Techniques: Expressing, CUT&Tag

Shown are the results from the dual luciferase reporter assay in C2C12 myotubes co-transfected with either the full-length h KCNH2 :LUC or Δh KCNH2 :LUC (E-box deletion) construct, together with BMAL1 and either wild-type CLOCK or the dominant-negative CLOCKΔ19. Relative luciferase activity (normalized to Renilla control) is shown for each condition. BMAL1:CLOCK transactivated the full-length h KCNH2 promoter. This transactivation was significantly reduced by co-expression of CLOCKΔ19 and by deletion of the tandem E-box. Co-expression of CLOCKΔ19 with the Δh KCNH2 :LUC construct did not further reduce promoter activity relative to Δh KCNH2 :LUC alone, indicating that BMAL1:CLOCK drives h KCNH2 transcription primarily through the tandem E-box. n = 14/3 separate transfections for h KCNH2 :LUC conditions; n = 8/3 separate transfections for Δh KCNH2 :LUC conditions. *p < 0.05, **p < 0.01.

Journal: bioRxiv

Article Title: The circadian clock regulates KCNH2 (hERG) promoter activity through daily temperature rhythms

doi: 10.64898/2026.09.28.751769

Figure Lengend Snippet: Shown are the results from the dual luciferase reporter assay in C2C12 myotubes co-transfected with either the full-length h KCNH2 :LUC or Δh KCNH2 :LUC (E-box deletion) construct, together with BMAL1 and either wild-type CLOCK or the dominant-negative CLOCKΔ19. Relative luciferase activity (normalized to Renilla control) is shown for each condition. BMAL1:CLOCK transactivated the full-length h KCNH2 promoter. This transactivation was significantly reduced by co-expression of CLOCKΔ19 and by deletion of the tandem E-box. Co-expression of CLOCKΔ19 with the Δh KCNH2 :LUC construct did not further reduce promoter activity relative to Δh KCNH2 :LUC alone, indicating that BMAL1:CLOCK drives h KCNH2 transcription primarily through the tandem E-box. n = 14/3 separate transfections for h KCNH2 :LUC conditions; n = 8/3 separate transfections for Δh KCNH2 :LUC conditions. *p < 0.05, **p < 0.01.

Article Snippet: Mouse C2C12 myoblasts (ATCC; CRL-1772) grown in DMEM (Gibco; 11995-065) growth media (10% fetal bovine serum (Atlanta Biologicals; S11150); 1% Penicillin Streptomycin (ThermoFisher; 15140-122)) were transiently transfected with WT or mutant h KCNH2 promoter-reporter plasmids using standard protocols for Polyjet Transfection Reagent (SignaGen; SL 100688).

Techniques: Luciferase, Transfection, Construct, Dominant Negative Mutation, Activity Assay, Control, Expressing

Polar plot comparing peak phase and phase coherence (radius; vector length = mean coherence r) for Bmal1 :LUC, Per1 :LUC, and h KCNH2 :LUC under temperature cycling is shown. h KCNH2 phase-clustered closely with Per1 (12.1 h vs. 9.6 h) rather than with Bmal1 (21.1 h), consistent with h KCNH2 being regulated downstream of the core negative-feedback arm of the circadian clock. Right panel. Bmal1 , Per1 , and Kcnh2 mRNA expression (counts per million, CPM) in mouse heart across circadian time (CT), obtained from CircaDB . Shaded regions indicate the dark (active) phase. Fitted phase is shown for each gene in CT hours: Bmal1 phase = 0, Per1 phase = 10, Kcnh2 phase = 12. Because core body temperature is itself entrained to the rest-activity cycle, a trough occurs during the rest (light) and a peak during the active phase (dark). Phase relative to CT in vivo and phase relative to the temperature cycle in vitro (left panel) reflect similar underlying physiological timing. The relative phase relationship between these three genes parallels their C2C12 promoter-reporter counterparts, supporting the physiological relevance of the in vitro findings. Bmal1 :LUC n = 21, Per1 :LUC n = 20, h KCNH2 :LUC n = 39.

Journal: bioRxiv

Article Title: The circadian clock regulates KCNH2 (hERG) promoter activity through daily temperature rhythms

doi: 10.64898/2026.09.28.751769

Figure Lengend Snippet: Polar plot comparing peak phase and phase coherence (radius; vector length = mean coherence r) for Bmal1 :LUC, Per1 :LUC, and h KCNH2 :LUC under temperature cycling is shown. h KCNH2 phase-clustered closely with Per1 (12.1 h vs. 9.6 h) rather than with Bmal1 (21.1 h), consistent with h KCNH2 being regulated downstream of the core negative-feedback arm of the circadian clock. Right panel. Bmal1 , Per1 , and Kcnh2 mRNA expression (counts per million, CPM) in mouse heart across circadian time (CT), obtained from CircaDB . Shaded regions indicate the dark (active) phase. Fitted phase is shown for each gene in CT hours: Bmal1 phase = 0, Per1 phase = 10, Kcnh2 phase = 12. Because core body temperature is itself entrained to the rest-activity cycle, a trough occurs during the rest (light) and a peak during the active phase (dark). Phase relative to CT in vivo and phase relative to the temperature cycle in vitro (left panel) reflect similar underlying physiological timing. The relative phase relationship between these three genes parallels their C2C12 promoter-reporter counterparts, supporting the physiological relevance of the in vitro findings. Bmal1 :LUC n = 21, Per1 :LUC n = 20, h KCNH2 :LUC n = 39.

Article Snippet: Mouse C2C12 myoblasts (ATCC; CRL-1772) grown in DMEM (Gibco; 11995-065) growth media (10% fetal bovine serum (Atlanta Biologicals; S11150); 1% Penicillin Streptomycin (ThermoFisher; 15140-122)) were transiently transfected with WT or mutant h KCNH2 promoter-reporter plasmids using standard protocols for Polyjet Transfection Reagent (SignaGen; SL 100688).

Techniques: Plasmid Preparation, Expressing, Activity Assay, In Vivo, In Vitro